Abstract:Glycosylation, a prevalent post-translational modification, plays a pivotal role in regulating intricate cellular processes by covalently attaching glycans to macromolecules. Dysregulated glycosylation is linked to a spectrum of diseases, encompassing cancer, neurodegenerative disorders, congenital disorders, infections, and inflammation. This review delves into the intricate interplay between glycosylation and protein conformation, with a specific focus on the profound impact of N-glycans on the selection of distinct protein conformations characterized by distinct interactomes—namely, protein assemblies—under normal and pathological conditions across various diseases. We begin by examining the spike protein of the SARS virus, illustrating how N-glycans regulate the infectivity of pathogenic agents. Subsequently, we utilize the prion protein and the chaperone glucose-regulated protein 94 as examples, exploring instances where N-glycosylation transforms physiological protein structures into disease-associated forms. Unraveling these connections provides valuable insights into potential therapeutic avenues and a deeper comprehension of the molecular intricacies that underlie disease conditions. This exploration of glycosylation's influence on protein conformation effectively bridges the gap between the glycome and disease, offering a comprehensive perspective on the therapeutic implications of targeting conformational mutants and their pathologic assemblies in various diseases. The goal is to unravel the nuances of these post-translational modifications, shedding light on how they contribute to the intricate interplay between protein conformation, assembly, and disease.

What problem does this paper attempt to address?

The paper aims to explore how N-glycosylation regulates protein conformation and its role in diseases. Specifically, the authors focus on the impact of N-glycosylation on the selection of different protein conformations, which have distinct interactomes (i.e., protein assemblies) that vary under normal and pathological conditions. The paper first demonstrates how N-glycosylation regulates the infectivity of pathogens by analyzing the spike protein of the SARS virus. Then, using prion proteins and glucose-regulated protein 94 (GRP94) as examples, it discusses how N-glycosylation transforms normal protein structures into disease-associated forms. By revealing these connections, the research provides valuable insights into potential therapeutic avenues and deepens the understanding of the molecular complexities leading to disease conditions. By exploring the impact of glycosylation on protein conformation, the paper effectively bridges the gap between the glycome and diseases, elucidating the therapeutic significance of conformational mutations and their pathological assemblies for various diseases. The goal of the paper is to uncover the nuances of these post-translational modifications and clarify how they influence the complex interactions between protein conformation, assembly, and disease.

N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease